IFNs were able to mediate VEFG production from human mast cells31 and also in chronic myeloid leukaemia patients, imatinib in combination with pegylated‐IFN‐α2a was able to regulate VEGF levels.32 Here, IFNA2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.